Australia's Vitura Health jumps on distribution deal
17/03/2026 02:41
** Vitura Health VIT.AX jumps 12.8% to A$0.044, highest since March 4; set for best day since February 14, 2025 ** Diversified digital health business enters distribution agreement with MedReleaf Australia, enabling MedReleaf's full portfolio of medical cannabis products to be available on co's Canview platform ** Says agreement has potential to contribute up to ~A$15 mln ($10.6 mln) in additional annual revenue across distribution channels ** YTD, VIT down 27.9% ($1 = A$1.4118) (Reporting by Shruti Agarwal in Bengaluru) ((Shruti.Agarwal@thomsonreuters.com))
Recent news on Vitura Health
See all newsAustralia's Vitura Health gains on quarterly profit jump
Australia's Vitura Health hits record low on FY27 revenue warning
Brief: Vitura Health Says Bupa To Redirect All International-Member Telehealth Referrals
Australia's Vitura Health slips after company flags FY27 revenue impact
Brief: Vitura Health Appoints Tom Howitt As Interim CFO Effective Immediately